© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy
Department of Internal Medicine D, University of Münster, Albert-Schweitzer-Strasse 33, D-48129, Münster, Germany
* Corresponding author. Tel.: +49-251-834-7523; fax: +49-251-834-7545 koschm{at}uni-muenster.de
Objective: The endothelium is a newly recognised target tissue of parathyroid hormone (PTH). It is not clear whether hyperparathyroidism affects endothelial function and whether parathyroidectomy (Ptx) has an influence on arterial vessel wall properties. We studied brachial flow-mediated vasodilation (FMD) and brachial and carotid intima-media thickness (IMT) in patients with primary hyperparathyroidism (pHPT) before and after Ptx and in healthy controls. Methods: 19 patients with pHPT (mean+SEM, age 45±4.7 years, PTH 238±52 ng/l) were studied. Diabetes, hypertension and vascular disease were excluded. Twenty healthy volunteers matched for age, sex and blood pressure served as controls. Enddiastolic diameter, FMD and nitroglycerine-induced (NMD) dilation of the brachial artery were measured by a multigate pulsed doppler system (echo-tracking), IMT was determined using automatic analysis of the M-line signal. Healthy volunteers where studied on one occasion, patients were studied at baseline and 6 months after Ptx. Results: Six months after Ptx PTH had decreased to normal, blood pressure levels remained unchanged. Endothelium dependent FMD at baseline was impaired in patients compared to controls (4.7±1.2 vs. 18.2±3.7%, P<0.01), however, FMD improved significantly after Ptx (16.7±3.0%, P<0.01). Nitroglycerine-induced dilation, IMT and artery diameter were not different between groups and did not change after Ptx. Conclusions: Impaired endothelium dependent vasodilation in patients with primary hyperparathyroidism improves after successful parathyroidectomy. Endothelial dysfunction associated with primary hyperparathyroidism occurs without detectable structural wall alterations of the brachial artery and appears therefore to be an early and reversible arterial alteration.
KEYWORDS Hormones; Endothelial function; Ultrasound; Blood flow; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C J Ferro, C D Chue, R P Steeds, and J N Townend Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart, November 1, 2009; 95(21): 1770 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Drechsler, V. Krane, D. C Grootendorst, E. Ritz, K. Winkler, W. Marz, F. Dekker, C. Wanner, and for the German Diabetes and Dialysis Study Investi The association between parathyroid hormone and mortality in dialysis patients is modified by wasting Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3151 - 3157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Walker, J. Fleischer, T. Rundek, D. J. McMahon, S. Homma, R. Sacco, and S. J. Silverberg Carotid Vascular Abnormalities in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3849 - 3856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Walker, D. J. McMahon, W. B. Inabnet, R. M. Lazar, I. Brown, S. Vardy, F. Cosman, and S. J. Silverberg Neuropsychological Features in Primary Hyperparathyroidism: A Prospective Study J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1506 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Silverberg, E. M. Lewiecki, L. Mosekilde, M. Peacock, and M. R. Rubin Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 351 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gnudi Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 24 - 26. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Towler Calciotropic Hormones and Arterial Physiology: "D"-lightful Insights J. Am. Soc. Nephrol., February 1, 2007; 18(2): 369 - 373. [Full Text] [PDF]
|
|
|
|
|
|
Y. Slinin, R. N. Foley, and A. J. Collins Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1788 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ogata, E. Ritz, G. Odoni, K. Amann, and S. R. Orth Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors J. Am. Soc. Nephrol., April 1, 2003; 14(4): 959 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Malik, D. Wichterle, V. Melenovsky, and J. Simek Von Willebrand factor and assessment of endothelial function Cardiovasc Res, April 1, 2002; 54(1): 193 - 194. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gaenzer, G. Neumayr, P. Marschang, W. Sturm, R. Kirchmair, and J. R. Patsch Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|